Lb Pharmaceuticals LBRX Ratios (2024-2026)

NASDAQ LBRX
$37.28 -0.61 (-1.61%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Lb Pharmaceuticals Quarterly Ratios

Periods 7 quarters
Latest Jun 2026

Lb Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 7 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 316.84M353.21M377.59M
Equity AverageEquity Avg. -93.00M-96.95M-101.61M103.17M305.77M340.00M355.52M
Valuation
Price to EarningsP/E 2.07
Price to BookP/B 0.300.591.872.80
Enterprise Value -222.79M-116.13M341.49M603.20M
Market Capitalization 91.69M179.08M707.12M930.99M
Return Ratios
Return on Capital Employed [ROCE]ROCE -8.15%-11.38%-24.20%
Return on Assets [ROA]ROA -7.96%-11.03%-22.69%
Return on Equity [ROE]ROE -18.23%-8.24%-11.46%-24.10%

Lb Pharmaceuticals Ratios API

Pull Lb Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LBRX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY